Furthermore, in the SIRT1 transgenic mice, tumor growth was decreased when the deacetylase activity of SIRT1 was blocked with the administration of the class III HDAC inhibitor nicotinamide (Fig. 4B). This evidence concerns the gene HDAC9 and neoplasm.